Related Experiment Video
Updated: Aug 15, 2025

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
Published on: January 17, 2012
Genetic Arg-304-His substitution in GRK5 protects against sepsis progression by alleviating NF-κB-mediated
Mingwei Xu1, Yiming Shao2, Kaisheng Lin1
1Jieyang Medical Research Center, Jieyang People's Hospital, Jieyang Affiliated Hospital of Sun Yat-sen University, Jieyang, Guangdong, PR China.
Background:
Previous studies have demonstrated that G protein-coupled receptor kinase 5 (GRK5) exerts a pivotal regulatory effect on the inflammation associated with sepsis. The present study aimed to investigate the clinical association of GRK5 genetic variants with sepsis and to further explore the underlying genetic mechanisms involved in regulating sepsis-induced inflammatory responses and the pathogenesis of sepsis.
Methods:
This case-control study enrolled 1081 septic patients and 1147 matched controls for genotyping of GRK5 rs2230349 and rs2230345 polymorphisms. The effect of these genetic variants on GRK5-mediated inflammatory responses was analyzed in peripheral blood mononuclear cells (PBMCs) and THP-1 macrophages. A clinically relevant polymicrobial sepsis model was established by subjecting wild-type (WT) and GRK5-knockout mice to cecal ligation and puncture (CLP) to evaluate the role of GRK5 in sepsis.
Results:
We identified significant differences in the genotype/allele distribution of rs2230349 G > A, but not rs2230345, between the sepsis subtype and septic shock subgroups (GA + AA vs. GG genotype, OR = 0.698, 95% CI = 0.547-0.893, P = 0.004; A vs. G allele, OR = 0.753, 95% CI = 0.620-0.919, P = 0.005) and between the survivor and nonsurvivor subgroups (GA + AA vs. GG genotype, OR = 0.702, 95% CI = 0.531-0.929, P = 0.015; A vs. G allele, OR = 0.753, 95% CI = 0.298-0.949, P = 0.017). PBMCs carrying the sepsis-associated protective A allele produced significantly lower levels of TNF-α and IL-1β upon LPS stimulation. The results from the in vitro experiment showed that the Arg-304-His substitution caused by the rs2230349 G-to-A mutation in GRK5 significantly decreased the LPS-induced production of several proinflammatory cytokines, such as TNF-α, IL-6, IL-1β and MCP-1, via the IκB-α/NF-κB signaling pathway in THP-1 macrophages. Furthermore, GRK5-knockout mice exhibited a significant decrease in IκB-α phosphorylation/degradation, the p-p65/p65 ratio, the p-p50/p50 ratio, p65 nuclear translocation and downstream cytokine (TNF-α, IL-6, IL-1β and VCAM-1) production compared to WT mice after CLP surgery. A significant improvement in 7-day survival rate in GRK5-KO septic mice was observed in the presence of antibiotics.
Conclusions:
The Arg-304-His substitution caused by the rs2230349 G-to-A mutation in GRK5 might disrupt GRK5 function and alleviate IKB-α/NF-κB-mediated inflammatory responses, which ultimately conferred a genetic protective effect against susceptibility to sepsis progression and mortality. These results may, to some extent, explain the heterogeneity of the clinical prognoses of septic patients and provide novel opportunities for individualized approaches for sepsis treatment.
Insights
Genetic variants in GRK5 influence sepsis outcomes. The rs2230349 G-to-A mutation in GRK5 may offer protection against sepsis progression and mortality by reducing inflammatory responses. This finding could lead to personalized sepsis treatments.
Area of Science:
- Genetics
- Immunology
- Sepsis Pathogenesis
Background:
- G protein-coupled receptor kinase 5 (GRK5) plays a key role in regulating inflammation during sepsis.
- Previous research highlights GRK5's involvement in sepsis-related inflammatory processes.
Purpose of the Study:
- To investigate the clinical association between GRK5 genetic variants and sepsis.
- To explore the mechanisms by which these variants regulate sepsis-induced inflammation and pathogenesis.
Main Methods:
- A case-control study involving 1081 septic patients and 1147 controls genotyped for GRK5 polymorphisms (rs2230349 and rs2230345).
- Analysis of genetic variants' effects on GRK5-mediated inflammation in peripheral blood mononuclear cells (PBMCs) and THP-1 macrophages.
- Evaluation of GRK5's role in a mouse sepsis model (cecal ligation and puncture) using wild-type and GRK5-knockout mice.
Main Results:
- The GRK5 rs2230349 G>A polymorphism was significantly associated with sepsis subtypes, septic shock, and survival rates.
- The protective 'A' allele in rs2230349 was linked to lower production of pro-inflammatory cytokines (TNF-α, IL-1β) in PBMCs.
- In vitro and in vivo studies demonstrated that the Arg-304-His substitution (rs2230349 G>A) in GRK5 reduced inflammatory cytokine production via the IκB-α/NF-κB pathway and improved survival in GRK5-knockout mice.
Conclusions:
- The rs2230349 G-to-A mutation in GRK5 may confer a protective genetic effect against sepsis progression and mortality.
- This mutation appears to alleviate inflammatory responses mediated by the IκB-α/NF-κB pathway.
- Findings may explain clinical prognosis heterogeneity in sepsis and suggest avenues for personalized treatment strategies.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
GPCR Desensitization

